447 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Exosome Diagnostics Funding History

Since Exosome Diagnostics was founded in 2008, it has participated in 7 rounds of funding. In total Exosome Diagnostics has raised $106.9M. Exosome Diagnostics' last funding round was on Jun 2017 for a total of $30.3M.

Exosome Diagnostics Funding Rounds

Unlock 4 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series C
Jun 2017
$30.3M
7
Forbion Capital Partners,  Blue Ridge Capital,  NGN Capital,  Arcus Ventures,  b-to-v Partners,  CD Ventures,  Tiger Partners
Series B
Jan 2016
$16M
6
Forbion Capital Partners,  NGN Capital,  CD Ventures,  Qiagen,  Arcus Ventures,  Blue Ridge Capital
Series B
Aug 2015
$15.5M
4
Forbion Capital Partners,  NGN-Capital,  Arcus Ventures,  CD Ventures
Equity
Jun 2015
$1.5M
__
Series B
Mar 2014
$27.1M
6
Arcus Ventures,  QIAGEN,  Monashee Capital,  NGN Capital LLC,  Forbion Capital Partners,  CD Ventures

Total Funding: $106.9M

Exosome Diagnostics Investors

Unlock 10 more investors →

INVESTOR

ROUND

FUNDING DATE

Forbion Capital Partners
Series C, Series B, Debt, Series A
Jun 2017, Jan 2016, Aug 2015, Mar 2014, Aug 2012, Apr 2010
Blue Ridge Capital
Series C, Series B
Jun 2017, Jan 2016
NGN Capital
Series C, Series B, Debt, Series A
Jun 2017, Jan 2016, Aug 2012, Apr 2010
Arcus Ventures
Series C, Series B
Jun 2017, Jan 2016, Aug 2015, Mar 2014
b-to-v Partners
Series C
Jun 2017

Total Investors: 13

Exosome Diagnostics has 13 investors, including Forbion Capital Partners, Blue Ridge Capital and NGN Capital. The latest investment occurred in Jun 2017.